|Editorial  board | About the Journal   | Instructions for Authors | Peer Review Policy | Clinical and Experimental Work Code |   Contact  |
 

Acta Medica Medianae
Vol. 48, No2 , April, 2009
UDK 61
YU ISSN 0365-4478

 

Correspondence to:
Ljiljana Ristić

Public Health Institute Nis, Center for Microbiology

50 Dr Zoran  Djindjic Blvd.

18000 Nis

Phone: 060 7000337

E-mail: rileiljilja@yahoo.com

 

 

 

 

 

 

 

 

Original article
UDC:
616.98-078:579.835

 

PRESENCE OF RESISTANCE IN CAMPYLOBACTER JEJUNI AND CAMPYLOBACTER COLI

 

Ljiljana Ristic, Tatjana Babic, Branislava Kocic, Biljana Miljkovic-Selimovic

 

Public Health Institute Nis, Center for Microbiology

 

There are 18 species belonging to the genus of Campylobacter (rRNK group I), of which thermophilic ones are the following: Campylobacter jejuni, Campylobacter coli, Campylobacter lari and Campylobacter upsaliensis. The aim of our research was to determine the sensitivity of  Campylobacter species, isolated from human feces, to  antibiotics being used in practice. The study involved 50 human strains of C. jejuni/coli isolated from feces in the Centre for Microbiology in the Public Health Institute Nis. Sensitivity was tested by applying the disk diffusion method on seven antibiotics (erythromycin, gentamicin, tetracycline, ciprofloxacin, hloramphenicol, cephalexin and nalidixic acid). Our results showed low resistance to erythromycin, gentamicin and tetracycline (2%), which corresponds to the studies conducted in the world. Moreover, these findings indicate that erythromycin may be considered the drug of choice in the treatment of Campylobacter diarrhea in this region. Resistance to fluoroquinolone and  nalidixic acid was 44%, and C. coli showed higher resistance compared to C. jejuni, though statistical significance was not proved. Acta Medica Medianae 2009;48(2):14-17.

 

Key words: Campylobacter jejuni, Campylobacter coli, resistance, disk diffusion, antibiotics